Cogent Biosciences (COGT) Enterprise Value (2017 - 2021)
Cogent Biosciences (COGT) has 4 years of Enterprise Value data on record, last reported at -$202.9 million in Q3 2021.
- For Q3 2021, Enterprise Value fell 56.77% year-over-year to -$202.9 million; the TTM value through Sep 2021 reached -$202.9 million, down 56.77%, while the annual FY2020 figure was -$242.2 million, 547.15% down from the prior year.
- Enterprise Value reached -$202.9 million in Q3 2021 per COGT's latest filing, up from -$218.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$484000.0 in Q3 2019 and bottomed at -$242.2 million in Q4 2020.
- Average Enterprise Value over 4 years is -$105.8 million, with a median of -$80.4 million recorded in 2018.
- Peak YoY movement for Enterprise Value: skyrocketed 52.38% in 2019, then plummeted 47279.67% in 2021.
- A 4-year view of Enterprise Value shows it stood at -$78.6 million in 2018, then surged by 52.38% to -$37.4 million in 2019, then plummeted by 547.15% to -$242.2 million in 2020, then rose by 16.23% to -$202.9 million in 2021.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$202.9 million in Q3 2021, -$218.1 million in Q2 2021, and -$230.7 million in Q1 2021.